JP2024546130A5 - - Google Patents
Info
- Publication number
- JP2024546130A5 JP2024546130A5 JP2024534730A JP2024534730A JP2024546130A5 JP 2024546130 A5 JP2024546130 A5 JP 2024546130A5 JP 2024534730 A JP2024534730 A JP 2024534730A JP 2024534730 A JP2024534730 A JP 2024534730A JP 2024546130 A5 JP2024546130 A5 JP 2024546130A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence ids
- sequence
- ids
- antibody
- adc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2117928.8A GB202117928D0 (en) | 2021-12-11 | 2021-12-11 | Immunotherapy for cancer |
| GB2117928.8 | 2021-12-11 | ||
| PCT/GB2022/053174 WO2023105248A1 (en) | 2021-12-11 | 2022-12-12 | Immunotherapy for cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546130A JP2024546130A (ja) | 2024-12-17 |
| JP2024546130A5 true JP2024546130A5 (https=) | 2025-12-18 |
Family
ID=80080108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534730A Pending JP2024546130A (ja) | 2021-12-11 | 2022-12-12 | 癌の免疫療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250152729A1 (https=) |
| EP (1) | EP4444751A1 (https=) |
| JP (1) | JP2024546130A (https=) |
| CA (1) | CA3240598A1 (https=) |
| GB (1) | GB202117928D0 (https=) |
| WO (1) | WO2023105248A1 (https=) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4151042A (en) | 1977-03-31 | 1979-04-24 | Takeda Chemical Industries, Ltd. | Method for producing maytansinol and its derivatives |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6441163B1 (en) | 2001-05-31 | 2002-08-27 | Immunogen, Inc. | Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| DK1523493T3 (da) | 2002-07-09 | 2013-12-02 | Alexander Doemling | Nye tubulysinanaloge |
| US7776814B2 (en) | 2002-07-09 | 2010-08-17 | R&D-Biopharmaceuticals Gmbh | Tubulysin conjugates |
| DE10254439A1 (de) | 2002-11-21 | 2004-06-03 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Tubulysine, Herstellungsverfahren und Tubulysin-Mittel |
| US20090075378A1 (en) | 2007-02-20 | 2009-03-19 | Anaptysbio, Inc. | Somatic hypermutation systems |
| US8476451B2 (en) | 2007-07-20 | 2013-07-02 | The Regents Of The University Of California | Tubulysin D analogues |
| EP2181101A2 (en) | 2007-07-20 | 2010-05-05 | Helmholtz-Zentrum für Infektionsforschung GmbH | Tubulysin d analogues |
| CN101909441B (zh) | 2007-10-25 | 2015-05-13 | 恩多塞特公司 | 微管蛋白抑制剂及其制备方法 |
| JP2013535220A (ja) | 2010-08-06 | 2013-09-12 | エンドサイト，インコーポレイテッド | ツブリシンを調製するためのプロセス |
| RU2014117952A (ru) * | 2011-10-06 | 2015-11-20 | Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем | Антитела против sema4a человека, используемые для лечения заболевания |
| EA032203B1 (ru) | 2014-04-11 | 2019-04-30 | МЕДИММЬЮН ЭлЭлСи | Производные тубулизина |
| EP4126243A4 (en) | 2020-03-27 | 2024-06-12 | The Trustees of Indiana University | Immunotherapeutic targets in multiple myeloma and methods for their identification |
-
2021
- 2021-12-11 GB GBGB2117928.8A patent/GB202117928D0/en not_active Ceased
-
2022
- 2022-12-12 WO PCT/GB2022/053174 patent/WO2023105248A1/en not_active Ceased
- 2022-12-12 CA CA3240598A patent/CA3240598A1/en active Pending
- 2022-12-12 EP EP22843860.2A patent/EP4444751A1/en active Pending
- 2022-12-12 JP JP2024534730A patent/JP2024546130A/ja active Pending
- 2022-12-12 US US18/718,334 patent/US20250152729A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101529810B1 (ko) | 항체-약물 접합체 | |
| US9228023B2 (en) | Anti-ROR1 antibodies and methods of use for treatment of cancer | |
| CN110494448B (zh) | 包含抗-ly75抗体的医药组合 | |
| CN111110862A (zh) | 抗cldn18．2抗体的药物偶联体及其制备方法和用途 | |
| JP2015520758A (ja) | Ｃｄ３３抗体及び癌を処置するためのその使用 | |
| KR20160097336A (ko) | 신규 항-ｄｐｅｐ3 항체 및 이의 사용 방법 | |
| JP2022533538A5 (https=) | ||
| JP2008537673A5 (https=) | ||
| JP2020522281A5 (https=) | ||
| JP2020522280A5 (https=) | ||
| CN116390772A (zh) | 新型美登素类似物作为adc有效载荷及其在癌症治疗中的用途 | |
| JP2025513721A5 (https=) | ||
| JP2024546130A5 (https=) | ||
| CN112236143A (zh) | 医药组合 | |
| JP2024527235A5 (https=) | ||
| CN120829509A (zh) | 抗ror1抗体、其免疫缀合物及其应用 | |
| RU2021113726A (ru) | АНТИТЕЛА ПРОТИВ CD79b, КОНЪЮГАТЫ С ЛЕКАРСТВЕННЫМ СРЕДСТВОМ И ИХ ПРИМЕНЕНИЯ | |
| HK40064761B (zh) | 抗cd228抗体和抗体-药物缀合物 | |
| NZ761020B2 (en) | Cd38 modulating antibody | |
| NZ761020A (en) | Cd38 modulating antibody | |
| NZ760342B2 (en) | Cd38 modulating antibody | |
| HK1193052B (en) | Antibody-drug conjugates |